How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

18,217 results for

"grant funding" or "obtaining grants" or "getting grants" or "grant awards" or (grants and "how to")

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

17661. A Phase II Study on Immunogenicity and Safety of MVA-BN® (IMVAMUNE™) Smallpox Vaccine in Subjects With Atopic Dermatitis

( Other Grant/Funding Number: NIAID ) First Posted: April 21, 2006 Results First Posted: January 9, 2019 Last Update Posted: January 9, 2019 Last Verified: December 2018 Keywords provided by Bavarian Nordic: Atopic dermatitis Smallpox Vaccination Additional relevant MeSH terms: Layout table for MeSH terms Dermatitis Dermatitis, Atopic Eczema Smallpox Skin Diseases Skin Diseases, Genetic Genetic Diseases, Inborn Skin Diseases, Eczematous Hypersensitivity, Immediate Hypersensitivity Immune System

2006 Clinical Trials

17662. Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

information Responsible Party: University College, London ClinicalTrials.gov Identifier: Other Study ID Numbers: CDR0000457755 LLCG-TOPICAL EU-20313 ISRCTN ( Registry Identifier: 77383050 ) Cancer Research UK (CTAAC) ( Other Grant/Funding Number: C1438/A4147 ) Roche AG Pharma ( Other Grant/Funding Number: MO17591 ) UCL Trial Sponsor reference ( Other Identifier: UCL/05/173 ) EudraCT number ( Other Identifier: 2004-000729-31 ) First Posted: January 11, 2006 Last Update Posted: December 3, 2014 Last (...) Collaborators: Cancer Research UK Roche Pharma AG Information provided by (Responsible Party): University College, London Study Details Study Description Go to Brief Summary: RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. It is not yet known whether erlotinib is more effective than a placebo in treating non-small cell lung cancer. PURPOSE: This randomized phase III trial is studying erlotinib to see how well it works compared to a placebo

2006 Clinical Trials

17663. Bone Marrow Cell Gene Transfer in Individuals With Fanconi Anemia

for additonal information Responsible Party: David Williams, Professor of Pediatrics, Boston Children’s Hospital ClinicalTrials.gov Identifier: Other Study ID Numbers: 382 CCHMCEH002 ( Other Grant/Funding Number: CCHMC ) First Posted: January 9, 2006 Last Update Posted: June 23, 2017 Last Verified: June 2017 Individual Participant Data (IPD) Sharing Statement: Plan to Share IPD: No Additional relevant MeSH terms: Layout table for MeSH terms Anemia Fanconi Anemia Fanconi Syndrome Hematologic Diseases Anemia

2006 Clinical Trials

17664. Family Help Program: Nighttime Enuresis Treatment Program

Grant/Funding Number: Canadian Institutes of Health Research (CIHR) ) First Posted: December 28, 2005 Last Update Posted: September 2, 2016 Last Verified: September 2016 Individual Participant Data (IPD) Sharing Statement: Plan to Share IPD: No Plan Description: Aggregate summary data would be made available but not individual data. Additional relevant MeSH terms: Layout table for MeSH terms Enuresis Urinary Incontinence Nocturnal Enuresis Urination Disorders Urologic Diseases Behavioral Symptoms

2005 Clinical Trials

17665. Age-Related Eye Disease Study 2 (AREDS2)

SanGiovanni, Sc.D. National Eye Institute, National Institutes of Health More Information Go to Additional Information: Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number): Layout table for additonal information Responsible Party: National Eye Institute (NEI) ClinicalTrials.gov Identifier: Obsolete Identifiers: NCT00409513 Other Study ID Numbers: NEI-120 N01-EY-5-0007 ( Other Grant/Funding Number: NIH ) HHS-N-260-2005-00007-C ( Other Grant/Funding Number: HHS

2006 Clinical Trials

17666. Clonidine Versus Adenosine to Treat Neuropathic Pain

and Stroke (NINDS) Information provided by (Responsible Party): Wake Forest University Health Sciences Study Details Study Description Go to Brief Summary: The purpose of this study is to determine the effects of clonidine and adenosine on nerve pain. Condition or disease Intervention/treatment Phase Pain Drug: clonidine Drug: adenosine Drug: placebo Phase 2 Detailed Description: This study is part of a pain center grant that focuses on how pain, especially chronic neuropathic pain, alters the response

2006 Clinical Trials

17667. Motivating Factors That Play a Role in Bulimia Nervosa

at Columbia University Medical Center More Information Go to Layout table for additonal information Responsible Party: New York State Psychiatric Institute ClinicalTrials.gov Identifier: Other Study ID Numbers: #5049/#6178R DNBBS 72-NBR ( Other Grant/Funding Number: DNBBS 72-NBR ) First Posted: March 17, 2006 Last Update Posted: May 24, 2016 Last Verified: May 2016 Additional relevant MeSH terms: Layout table for MeSH terms Feeding and Eating Disorders Bulimia Bulimia Nervosa Mental Disorders Hyperphagia

2006 Clinical Trials

17668. Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors

or by stopping them from dividing. Radiation therapy uses high-energy x-rays to kill tumor cells. Giving combination chemotherapy with or without radiation therapy before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed. Giving combination chemotherapy after surgery may kill any tumor cells that remain after surgery. PURPOSE: This phase II trial is studying how well combination chemotherapy works in treating patients with stage III or stage IV malignant (...) United States, California Sarcoma Oncology Center Santa Monica, California, United States, 90403 United States, Illinois Children's Memorial Hospital - Chicago Chicago, Illinois, United States, 60614 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202-5289 United States, Iowa University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242 United States, Maryland Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Warren Grant Magnuson Clinical

2006 Clinical Trials

17669. AZD2171 in Treating Patients With Recurrent Glioblastoma Multiforme

) ClinicalTrials.gov Identifier: Obsolete Identifiers: NCT00254943 Other Study ID Numbers: NCI-2009-00127 05-254 N02CO12400 ( Other Grant/Funding Number: US NIH Grant/Contract Award Number ) CDR0000460079 ( Registry Identifier: PDQ (Physician Data Query) ) First Posted: March 22, 2006 Last Update Posted: August 22, 2013 Last Verified: July 2013 Additional relevant MeSH terms: Layout table for MeSH terms Glioblastoma Gliosarcoma Astrocytoma Glioma Neoplasms, Neuroepithelial Neuroectodermal Tumors Neoplasms, Germ (...) Institute (NCI) Study Details Study Description Go to Brief Summary: This phase II trial is studying how well AZD2171 works in treating patients with recurrent glioblastoma multiforme. AZD2171 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor Condition or disease Intervention/treatment Phase Adult Giant Cell Glioblastoma Adult Glioblastoma Adult Gliosarcoma Recurrent Adult Brain Tumor Drug: cediranib maleate Phase 2 Detailed

2006 Clinical Trials

17670. Humoral Determinants of Immunity to Pneumococcal Infection

Medical Center, Houston Investigators Layout table for investigator information Principal Investigator: Daniel M Musher Michael E. DeBakey VA Medical Center, Houston, TX More Information Go to Layout table for additonal information Responsible Party: VA Office of Research and Development ClinicalTrials.gov Identifier: Other Study ID Numbers: INDB-013-05F H-16562 ( Other Grant/Funding Number: VA Medical Center, Houston ) First Posted: March 17, 2006 Last Update Posted: September 5, 2017 Last Verified

2006 Clinical Trials

17671. Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy

Information Go to Publications of Results: Layout table for additonal information Responsible Party: Northwell Health ClinicalTrials.gov Identifier: Other Study ID Numbers: DSIR 83-ATAP ( Other Grant/Funding Number: National Institute of Mental Health ) First Posted: May 29, 2006 Results First Posted: July 10, 2018 Last Update Posted: July 10, 2018 Last Verified: June 2018 Keywords provided by Northwell Health: Relapse Prevention Schizophrenia Injectable Medication Additional relevant MeSH terms: Layout (...) the risk of relapse and re-hospitalization. This study will determine how effective long-acting injectable risperidone is compared to oral antipsychotic medications to help patients who have schizophrenia. Patients who enroll in the study will be randomly assigned to receive either long-acting injectable risperidone or to receive oral "atypical" antipsychotic medication. The "atypical" antipsychotics that are included for patients in the oral group are: aripiprazole, olanzapine, quetiapine, risperidone

2006 Clinical Trials

17672. Impact of An Emergency Response System on Anxiety and Health-Care Use

to summon assistance from anywhere in their home, and may provide another option. Objectives: To see how an ERS affects patients’ anxiety, fear of falling, and use of the health-care system after discharge. We will study patients over 70 years of age who have fallen but do not need to be hospitalized. Our belief is that the ERS will improve patient anxiety, and may prevent return visits to the Emergency or episodes of prolonged immobilization after a fall. Methods: Patients agreeing to participate (...) of an emergency alarm system for the aged: a final report. Boston, MA: Hebrew Rehabilitation Center for Aged; 1980. Grant No. HSO1788. Dibner A. Personal emergency response systems: comunication technology aids eldery and their family. J Appl Gerontol. 1990;9:504-510. Layout table for additonal information ClinicalTrials.gov Identifier: Other Study ID Numbers: 205-2002 PSIF Grant #02-13 First Posted: May 29, 2006 Last Update Posted: May 29, 2006 Last Verified: September 2004 Keywords provided by Sunnybrook

2006 Clinical Trials

17673. AZD2171 and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer

with combination chemotherapy before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed and may kill more tumor cells. PURPOSE: This randomized clinical trial is studying how well giving AZD2171 together with combination chemotherapy works in treating women with locally advanced breast cancer. Condition or disease Intervention/treatment Phase Breast Cancer Biological: filgrastim Biological: pegfilgrastim Drug: cediranib maleate Drug: cyclophosphamide Drug (...) . Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00310089 Locations Layout table for location information United States, Maryland Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 United States, New Jersey Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick, New Jersey, United States, 08903 Sponsors and Collaborators National Cancer Institute (NCI) Investigators

2006 Clinical Trials

17674. Acupressure in Preventing Nausea and Vomiting in Young Cancer Patients Receiving Chemotherapy

Forest University Health Sciences Collaborator: National Cancer Institute (NCI) Information provided by (Responsible Party): Wake Forest University Health Sciences Study Details Study Description Go to Brief Summary: RATIONALE: Using acupressure wrist bands to press and stimulate nerves at an acupressure point on the inside of the wrist may help control nausea and vomiting caused by chemotherapy. PURPOSE: This randomized clinical trial is studying how well acupressure works in preventing nausea (...) -associated nausea and vomiting in children, when compared to placebo acupressure (wrist bands without acupressure). Develop a competitive grant application for a large, multi-institutional randomized controlled trial of the efficacy of acupressure in preventing chemotherapy-associated nausea in children. OUTLINE: This is a prospective, randomized, placebo-controlled, crossover, pilot study. Patients are randomized to 1 of 2 treatment arms. Arm I: Patients wear Sea-Band elastic acupressure wristbands

2006 Clinical Trials

17675. Cisplatin, Vinorelbine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

Investigators Layout table for investigator information Study Chair: Joe Maguire, MD Clatterbridge Centre for Oncology More Information Go to Layout table for additonal information Responsible Party: University College, London ClinicalTrials.gov Identifier: Other Study ID Numbers: CDR0000465629 C11922/A4558 ( Other Grant/Funding Number: Cancer Research UK ) 13746987 ( Other Identifier: ISRCTN ) EU-20602 ( Other Identifier: UCL CTC ) 2004-001920-19 ( EudraCT Number ) First Posted: April 3, 2006 Last Update (...) uses high-energy x-rays to kill tumor cells. It is not yet known whether giving combination chemotherapy followed by radiation therapy is more effective than giving combination chemotherapy together with radiation therapy followed by more chemotherapy in treating non-small cell lung cancer. PURPOSE: This randomized phase III trial is studying combination chemotherapy followed by radiation therapy to see how well it works compared to combination chemotherapy combined with radiation therapy followed

2006 Clinical Trials

17676. Biomechanical Analysis of Gait in Individuals With Duchenne Muscular Dystrophy

Hospitals for Children ClinicalTrials.gov Identifier: Other Study ID Numbers: SHC-DMD-79115 SHC-79115 ( Other Grant/Funding Number: Shriners Hospitals for Children ) First Posted: April 7, 2006 Last Update Posted: May 19, 2015 Last Verified: May 2015 Keywords provided by Michael D. Sussman, MD, Shriners Hospitals for Children: Walking Muscle Strength Energy Cost Quality of Life Additional relevant MeSH terms: Layout table for MeSH terms Muscular Dystrophies Muscular Dystrophy, Duchenne Muscular (...) ) ] quantitative assessment of strength with a Biodex energy cost of walking [ Time Frame: every six months (2x/year) ] assessment of how much energy it takes to walk, assessed with a Cosmed K4b2 gross motor functional skills [ Time Frame: every six months (2x/year) ] assessment of gross motor skills, ie getting up off the floor, ascending/descending stairs Step activity Monitor-participation [ Time Frame: one week every six months ] measurement of the number of steps taken in the community/home environment

2006 Clinical Trials

17677. Fatty Acid Binding Protein 2 (FABP2) Ancillary Proposal

Center More Information Go to Layout table for additonal information Responsible Party: US Department of Veterans Affairs ClinicalTrials.gov Identifier: Other Study ID Numbers: 465C 9066 ( Other Grant/Funding Number: Minnesota Medical Foundataion ) First Posted: November 21, 2005 Last Update Posted: May 23, 2014 Last Verified: May 2014 Additional relevant MeSH terms: Layout table for MeSH terms Diabetes Mellitus Diabetes Mellitus, Type 2 Glucose Metabolism Disorders Metabolic Diseases Endocrine

2005 Clinical Trials

17678. Sleep Homeostasis in Primary Insomnia Following Behavioral Treatment

. Perlis, Ph.D. University of Rochester More Information Go to Layout table for additonal information Responsible Party: Wilfred Pigeon, PhD, Associate Professor, University of Rochester ClinicalTrials.gov Identifier: Other Study ID Numbers: 33-CA-05 012331 ( Other Grant/Funding Number: American Sleep Medicine Foundation ) First Posted: November 21, 2005 Last Update Posted: January 12, 2016 Last Verified: January 2016 Keywords provided by Wilfred Pigeon, PhD, University of Rochester: Primary Insomnia (...) : somatic, cognitive, and cortical. The present study is focused on homeostatic abnormalities and secondarily on hyperarousal as exhibited in subjects with Primary Insomnia (PIs) compared to Good Sleeper controls (GSs). Homeostatic abnormalities will be assessed by evaluating how patients with insomnia respond to sleep deprivation. This study will use a Modified Sleep Deprivation and Multiple Sleep Latency Test (MSD/MSLT) procedure. Response to the procedure will be assessed in terms of sleep continuity

2005 Clinical Trials

17679. Pilot Study to Evaluate a Method of Controlling High Blood Sugar in the Pediatric Intensive Care Unit

data available and the impressive findings displayed in the adult literature, we performed a retrospective chart review of all pediatric patients admitted to our PICU over a 13 month period. The goals of this study were to gain a better understanding of current glucose monitoring techniques in the PICU as well how hyperglycemia correlates with morbidity and mortality in pediatrics. The results confirmed our hypothesis that a higher peak glucose during an admission is associated with longer LOS (...) University Sub-Investigator: Darrell M Wilson Stanford University More Information Go to Publications: Wintergerst KA, Buckingham B, Gandrud L, Kache S, Wilson DM. Hyperglycemia in the Pediatric Intensive Care Unit. Abstract. Diabetes Technology & Therapeutics 7(2):422, 2005. Layout table for additonal information ClinicalTrials.gov Identifier: Other Study ID Numbers: 95771 Medtronic Minimed - Pending NIH Training Grant - DK07217 First Posted: October 17, 2005 Last Update Posted: December 20, 2007 Last

2005 Clinical Trials

17680. Role of PET CT in Determining Target Volumes in Radiation Therapy for Lung Cancer

does not treat all the identified tumor then the chance for cure is lost. There have only been two previous reports of the ability of CT to determine the gross tumor volume and its extension. There are no similar reports using PET CT. This study will be the first of its kind to evaluate how accurate PET CT can be in detecting the gross tumor and its microscopic extension using the surgically removed tumor measurements as the gold standard. If PET CT is able to more accurately determine the tumor (...) to Publications of Results: Layout table for additonal information Responsible Party: Yee C. Ung, Sunnybrook Regional Cancer Centre ClinicalTrials.gov Identifier: Other Study ID Numbers: 04-may-00142 OCRN OCRN grant First Posted: September 22, 2005 Last Update Posted: February 5, 2009 Last Verified: February 2009 Keywords provided by Toronto Sunnybrook Regional Cancer Centre: Non-small cell lung cancer Positron emission tomography Gross tumor volume Radiation therapy Additional relevant MeSH terms: Layout

2005 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>